San Diego City Beat January 5, 2005 Originally appearing here. The San Diego City Beat published a discussion and analysis of a recent legal challenge to the HHS to change how marijuana is scheduled, with …
The Providence (RI) Journal published an excellent op-ed about the financial reasons why drug warriors don’t want to see the licensing of the UMass Amherst production facility.. The Providence Journal …
December 7, 2004 Souder is Right: Let's Prove that Marijuana is Safe Dear Colleague: Representative Souder recently circulated a Dear Colleague letter announcing the introduction of the "Safe and Effective …
Rep. Sam Farr (D-CA) has sent out a ‘Dear Colleague letter’ to all member of the US House of Representatives, in response to a bill filed by U.S. Rep. Mark Souder that seeks to have the National …
MAPS mailed petitions for reconsideration to the DC Circuit Court of Appeals, asking again for the Court to pressure HHS and DEA for not responding in 17 ½ months to our applications to purchase …
We have a decision regarding MAPS’ lawsuits against DEA and against HHS/NIH/NIDA regarding our claim of “unreasonable delay” in responding to MAPS-sponsored applications to NIDA to purchase …
Originally appearing here. Slate has recently published an extensive commentary on how the Supreme Court is and will approach Ashcroft v. Raich. MAPS had filed an amicus curiae concerning the obstruction …
MAPS initiates work on a legal motion for expedited scheduling of our lawsuits against DEA and against HHS/NIH/NIDA. It’s now been more than 3 1/2 months since July 21, 2004, when MAPS, Valerie Corral, …
Medical marijuana advocates likely to get a break under Kerry Democrat says he would stop pot club raids pushed by Bush San Francisco Chronicle, Sunday, October 10, 2004 http://sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2004/10/10/MNG0996S2L1.DTL …
The October 8-14 Boston Phoenix features an interview with MAPS’ president Rick Doblin Ph.D. that discusses, among other things, ongoing research into the therapeutic effects of MDMA, psilocybin, …
Reuters News Service published a story stating “British, French Drug Firms Lead in Marijuana Tests”, noting that US drug development is hampered by marijuana’s schedule 1 status and government …